LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $7,000 | +16.7% | 1,535 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 1,535 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -14.3% | 1,535 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +16.7% | 1,535 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 1,535 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | -57.1% | 1,535 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $14,000 | 0.0% | 1,535 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | +40.0% | 1,535 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | -28.6% | 1,535 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $14,000 | -54.8% | 1,535 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $31,000 | -31.1% | 1,535 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $45,000 | -2.2% | 1,535 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $46,000 | -6.1% | 1,535 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $49,000 | -5.8% | 1,535 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $52,000 | +13.0% | 1,535 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $46,000 | +27.8% | 1,535 | +27.7% | 0.00% | 0.0% |
| Q1 2017 | $36,000 | – | 1,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
| TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
| FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
| WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
| Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |